Physician profile
Matthew B Baker
NPI 1275540692
$3,012.58
in general payments reported to CMS, 2019-2025
12 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $388 · 2021: $273 · 2022: $438 · 2023: $394 · 2024: $929 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,148.67 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Allergan, INC. | $944.91 | 2019-2022 | |
| Sientra, INC. | $245.52 | 2019-2022 | |
| Davol INC. | $238.62 | 2022-2024 | Arista Ah Flexitip |
| Musculoskeletal Transplant Foundation INC. | $185.62 | 2020-2021 | |
| Tela Bio, INC. | $92.57 | 2024 | Ovitex 2s |
| Mentor Worldwide LLC | $41.98 | 2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Pacira Pharmaceuticals Incorporated | $40.54 | 2022-2024 | Exparel |
| Conmed Corporation | $22.04 | 2025 | Visiclear |
| Merck Sharp & Dohme LLC | $20.00 | 2022 | |
| Boston Scientific Corporation | $19.22 | 2025 | Angiojet Ultra 5000a |
| Medtronic, INC. | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.